Snowball logo
logo
CNCR

Loncar Cancer Immunotherapy ETF

CNCR NASDAQ
$9.02+$0.14  (1.58%)

Frequently asked questions

What is the Loncar Cancer Immunotherapy ETF (CNCR) expense ratio?

The Loncar Cancer Immunotherapy ETF funds expense ratio is 0.79%.

What is Loncar Cancer Immunotherapy ETF (CNCR) current stock price?

As of the latest data, Loncar Cancer Immunotherapy ETF stock price is $9.02, with a previous close of $8.88. Loncar Cancer Immunotherapy ETF gained $0.14 in the last trading session, representing a 1.58% increase.

Does Loncar Cancer Immunotherapy ETF (CNCR) pay dividends?

No. Loncar Cancer Immunotherapy ETF does not pay a dividend.